These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 23622392)

  • 1. Gangliosidoses.
    Patterson MC
    Handb Clin Neurol; 2013; 113():1707-8. PubMed ID: 23622392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry and genetics of gangliosidoses.
    Sandhoff K; Christomanou H
    Hum Genet; 1979; 50(2):107-43. PubMed ID: 116955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.
    Nestrasil I; Ahmed A; Utz JM; Rudser K; Whitley CB; Jarnes-Utz JR
    Mol Genet Metab; 2018 Feb; 123(2):97-104. PubMed ID: 29352662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of central nervous system inflammation in infantile and juvenile gangliosidoses.
    Utz JR; Crutcher T; Schneider J; Sorgen P; Whitley CB
    Mol Genet Metab; 2015 Feb; 114(2):274-80. PubMed ID: 25557439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis: Beyond Age of Onset.
    Kern J; Böhringer J; Timmann D; Trollmann R; Stendel C; Kamm C; Röbl M; Santhanakumaran V; Groeschel S; Beck-Wödl S; Göricke S; Krägeloh-Mann I; Synofzik M
    Neurology; 2024 Jan; 102(1):e207898. PubMed ID: 38165373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Laboratory Profile of Gangliosidosis from Southern Part of India.
    Gowda VK; Gupta P; Bharathi NK; Bhat M; Shivappa SK; Benakappa N
    J Pediatr Genet; 2022 Mar; 11(1):34-41. PubMed ID: 35186388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis.
    Sango K; McDonald MP; Crawley JN; Mack ML; Tifft CJ; Skop E; Starr CM; Hoffmann A; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1996 Nov; 14(3):348-52. PubMed ID: 8896570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.
    Maegawa GH; Stockley T; Tropak M; Banwell B; Blaser S; Kok F; Giugliani R; Mahuran D; Clarke JT
    Pediatrics; 2006 Nov; 118(5):e1550-62. PubMed ID: 17015493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.
    Agmon V; Khosravi R; Marchesini S; Dinur T; Dagan A; Gatt S; Navon R
    Clin Chim Acta; 1996 Mar; 247(1-2):105-20. PubMed ID: 8920231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.
    Gort L; de Olano N; Macías-Vidal J; Coll MA;
    Gene; 2012 Sep; 506(1):25-30. PubMed ID: 22789865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing Lysosomal Storage Disorders: The GM2 Gangliosidoses.
    Hall P; Minnich S; Teigen C; Raymond K
    Curr Protoc Hum Genet; 2014 Oct; 83():17.16.1-8. PubMed ID: 25271840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A possible biomarker of neurocytolysis in infantile gangliosidoses: aspartate transaminase.
    Kılıç M; Kasapkara ÇS; Kılavuz S; Mungan NÖ; Biberoğlu G
    Metab Brain Dis; 2019 Apr; 34(2):495-503. PubMed ID: 30712135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.
    Paw BH; Kaback MM; Neufeld EF
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2413-7. PubMed ID: 2522660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiological investigations in GM1 and GM2 gangliosidoses.
    Pampiglione G; Harden A
    Neuropediatrics; 1984 Sep; 15 Suppl():74-84. PubMed ID: 6100798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
    Tsuji D; Higashine Y; Matsuoka K; Sakuraba H; Itoh K
    Clin Chim Acta; 2007 Mar; 378(1-2):38-41. PubMed ID: 17196574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.
    Johnson WG; Cohen CS; Miranda AF; Waran SP; Chutorian AM
    Am J Hum Genet; 1980 Jul; 32(4):508-18. PubMed ID: 6772023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution loading tests in the study of genetic heterogeneity in gangliosidosis fibroblasts.
    Akhunov VS; Mirenburg TV; Krasnopolskaya XD
    J Inherit Metab Dis; 1994; 17(1):104-11. PubMed ID: 8051915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile gangliosidoses: Mapping a timeline of clinical changes.
    Jarnes Utz JR; Kim S; King K; Ziegler R; Schema L; Redtree ES; Whitley CB
    Mol Genet Metab; 2017 Jun; 121(2):170-179. PubMed ID: 28476546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inheritance of the enzyme defect in a new hexosaminidase deficiency disease.
    Johnson WG; Chutorian AB
    Ann Neurol; 1978 Nov; 4(5):399-403. PubMed ID: 104655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of microtechniques for the detection of lysosomal enzyme disorders: Tay-Sachs disease, Gm1-gangliosidosis and Fabry disease.
    Bladon MT; Milunsky A
    Clin Genet; 1978 Dec; 14(6):359-66. PubMed ID: 215359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.